We conducted a cross-sectional analysis to evaluate the relationship between serum antibody titers against 19 selected oral microorganisms and measures of hyperglycemia in a large, nationally representative data set. The study population consisted of 7,848 participants from the National Health and Nutrition Examination Survey III (1988)(1989)(1990)(1991)(1992)(1993)(1994) who were at least 40 yrs old, with complete serum IgG antibody data against 19 oral microorganisms. The 19 antibody titers were grouped into 4 categories via cluster analysis-orange-red, yellow-orange, orange-blue, and red-green-named to reflect predominant antibody titers against microorganisms in Socransky's classification scheme for oral microbes. Linear regression models weighted for complex survey design were used in which fasting blood glucose, fasting insulin, and HbA1c were outcomes and antibody cluster scores were exposures, adjusting for potential confounders. Higher orange-red cluster scores were associated with increased hyperglycemia, while higher orange-blue cluster scores were related with decreased hyperglycemia. A 1-unithigher orange-red cluster score was associated with 0.46 mg/dL higher fasting blood glucose (p = .0038), and a 1-unit-higher orange-blue cluster score was associated with 0.34% lower HbA1c (p = .0257). Groups of antibody titers against periodontal microorganisms were associated with hyperglycemia independent of known risk factors.
rEsEArch rEpOrts clinical IntrODuctIOn p eriodontal infection is associated with hyperglycemia and diabetes (Demmer et al., 2012; Borgnakke et al., 2013) . Approximately 11% of U.S. adults have diabetes, and 39% have moderate to severe periodontal disease (Eke et al., 2012) . Diabetes prevalence is approximately 4 times higher in people with the most severe periodontal damage (Choi et al., 2011) , and periodontal treatment in diabetes generally improves glycemic control (Engebretson and Kocher, 2013) ; however, a recent clinical trial of nonsurgical periodontal treatment showed otherwise .
There is emerging evidence to support the hypothesis that specific groups of periodontal microorganisms are associated with systemic outcomes. In a longitudinal analysis, carotid intimal medial thickness increase was attenuated with decreased counts of a selected group of oral microorganisms (Desvarieux et al., 2013) . Some studies have reported differences in the oral microorganism profile of individuals with and without type 2 diabetes (Ebersole et al., 2008; Makiura et al., 2008) , while others have not (Yuan et al., 2001; da Cruz et al., 2008; Field et al., 2012) . Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Prevotella spp., Fusobacterium spp., and a few other organisms have been associated with type 2 diabetes (Ebersole et al., 2008; Makiura et al., 2008; Casarin et al., 2013; Zhou et al., 2013) . The studies evaluating this relationship had small sample sizes and were heterogeneous with respect to method of microbial assessment, age, severity of periodontal disease, degree of diabetes control, and treatment of both periodontal disease and diabetes.
IgG antibody titers are produced in response to infections and remain elevated over a period of 30 mo even after periodontal treatment (Papapanou et al., 2004) , and P. gingivalus and A. actinomycetemcomitans were found stable over 15 yrs among individuals who had periodontitis (Lakio et al., 2009) . IgG antibody titers against oral microorganisms may therefore represent a cumulative measure of periodontal infection. In 2008, the Centers for Disease Control and Prevention released IgG antibody titer values for oral microorganisms (Vlachojannis et al., 2010) from analysis of stored serum samples of individuals who participated in the National Health and Nutrition Examination Survey III (NHANES III), conducted between 1988 and 1994. The analyses in this report are based on those data. The aim of this study was to evaluate the relationship between serum antibody titers against 19 selected microorganisms and measures of hyperglycemia in a large, nationally representative sample of U.S. adults. Oral Microorganisms and Hyperglycemia
MAtErIAls & MEthODs

Data source
We conducted a cross-sectional analysis of the NHANES III data, a nationally representative sample of the noninstitutionalized U.S. population, collected through multistage probability cluster sampling. The data included information on a variety of health risks and behaviors, diabetes, periodontal disease, and clinical and antibody information related to periodontal disease (Ezzati et al., 1992) .
The study population consisted of NHANES III participants who were at least 40 yrs old, with complete serum IgG antibody data against 19 oral microorganisms. Records of these individuals were linked with relevant dental, medical, socioeconomic, anthropometric, laboratory, and nutritional information available in NHANES III. All data for this report are available at http://www.cdc.gov/nchs/nhanes/nh3data.htm.
study population
Of 33,994 participants, 14,464 were at least 40 yrs old; 11,448 completed interviews; 9,379 underwent examinations; and 8,153 provided blood samples, which were analyzed for IgG antibody titer levels against a broad panel of 19 periodontal bacteria (Vlachojannis et al., 2010) . Individuals were excluded if they reported taking insulin (mostly type 1 diabetes) or had gestational diabetes, leaving 7,848 participants in the final sample.
IgG Assay for periodontal bacteria
Sera from 8,153 NHANES III participants aged 40+ yrs were tested for IgG antibodies against 19 oral bacterial species via the "checkerboard" immunoassay technique at the Oral and Diagnostic Sciences Laboratory, Columbia University College of Dental Medicine; results were reported in gravimetric units. Details are described in NHANES III documentation (Centers for Disease Control and Prevention, 2008) . The strains used to prepare whole cell antigenic extracts for checkerboard immunoassay are provided in the Appendix.
cluster Formation and naming the clusters Serum IgG antibody titer values for each bacterial species were natural log transformed and standardized by dividing by the logtransformed population standard deviation. To form antibody clusters, we used data from individuals with HbA1c ≥ 5.7 (n = 4,424). Standardized z scores of IgG antibodies against 19 periodontal bacteria were included in cluster analysis to derive 4 mutually distinct groups of IgG antibodies against periodontal bacteria, as described in the Figure. After deriving the clusters in this group, we calculated cluster scores for everybody in the population (healthy, prediabetes, diabetes) by summing z scores for each antibody titer (n = 7,874). For instance, one cluster consisted of P. melaninogenica, P. intermedia, P. nigrescens, and P. gingivalis. The z scores of these antibody titers were summed to obtain a score for that cluster.
To name the clusters, we adapted Socransky's color coding for periodontal bacteria as follows Haffajee, 2002, 2005) : Cluster 1 included antibodies against 4 organisms, of which 3 were from Socransky's orange complex and one was from the red complex; we named that cluster orange-red. Based on this approach, the 4 clusters were named orange-red, redgreen, yellow-orange, and orange-blue, as shown in the Figure. In Socransky's scheme, organisms in the red and orange clusters are related to periodontal disease; yellow and purple cluster organisms are associated with a healthy periodontal state; blue cluster organisms (including the Actinomyces sp.) are found in both periodontal disease and healthy states; and green complex organisms are weakly related to periodontal disease Haffajee, 2002, 2005) .
Exposure Measures
Cluster scores were computed for each individual in the study by summing the standardized z scores of IgG titers against oral microorganisms in each of the 4 clusters. These 4 cluster scores were the main exposure variables used in this analysis.
Outcome Measures
The 3 outcomes, which were log transformed, were fasting plasma insulin (n = 7,812), fasting plasma glucose (n = 7,812), and HbA1c percentage (n = 7,833).
covariate Information
Covariates included age, sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican American and others), income-to-poverty ratio (≤1.5, >1.5 to ≤3.0, and >3.0), years of formal education (≤6 yrs, 7 to 12 yrs, ≥13 yrs), smoking and alcohol intake (current, past, never), physical activity metabolic equivalents (active, ≥6; moderate, ≥4 to <6; less active, <4), central adiposity (≥101.6 cm for males and ≥88.9 cm for females) (Choi et al., 2011) , and diet (daily intake of calories; grams of carbohydrate, protein, fat, and fiber). Body mass index was computed from measured height and weight by dividing weight in kilograms by height in meters squared. Annual visits to the dentist was a binary variable (yes/no). Orange Descriptive statistics were estimated via procedures for complex surveys in SAS (proc surveymeans and proc surveyfreq) ( Table 1) . Linear regression models were run with logtransformed fasting plasma glucose, HbA1c, and fasting insulin as outcomes and with the 4 z score clusters as the predictors. The second model was adjusted for age and sex. The third model was further adjusted for race and ethnicity, income:poverty ratio, smoking, drinking alcohol, physical activity, fiber intake (continuous), dentist visits, waist circumference, and body mass index (continuous) ( Table 2) . These results were further stratified by teeth present (dentate and edentulous) ( Table 3 ) and periodontal status, as defined by Eke et al. (2012) : (1) no or mild periodontal destruction or (2) moderate or severe periodontal destruction (Table 4) .
rEsults
In this sample, 9.6% of individuals had diabetes, and 36.6% had prediabetes. Individuals with prediabetes or diabetes were more likely to be older, male, nonwhite, with <12 yrs of formal education, belonging to the lower and middle-income categories; they were more likely to be past or current smokers and alcohol drinkers, have higher adiposity measures, consume less fiber, miss >6 teeth, and be less likely to visit a dentist yearly (Table 1) .
Antibody clusters were associated with measures of hyperglycemia. A 1-unit-higher orange-red cluster score corresponded with 0.46 mg/dL higher fasting plasma glucose (p = .0038), and 1.69 µU/mL higher fasting insulin (p = .0494) after multivariable adjustment (Table 2 ). In contrast, a 1-unit-higher orangeblue cluster score was associated with 0.34% lower HbA1c (p = .0257). Red-green and yellow-orange clusters were not associated with any of the 3 hyperglycemia outcome measures (Table  2) . Among the dentate population, the orange-blue cluster remained inversely associated with HbA1c and the orange-red cluster positively associated with fasting insulin. The association between the orange-red cluster and fasting glucose was positive in the edentulous population and positive but nonsignificant in the dentate population (Table 3) . Among individuals with moderate or severe periodontal destruction, the orangeblue cluster remained inversely associated with HbA1c and the orange-red cluster positively associated with fasting insulin. These associations were qualitatively similar among individuals without periodontal disease, albeit they were not statistically significant (Table 4 ).
DIscussIOn
Antibody clusters were associated with measures of hyperglycemia independent of other risk factors. Orange-red antibody cluster scores were positively correlated with fasting plasma ratio, smoking, alcohol, physical activity, fiber intake, dentist visits, body mass index, and waist circumference. Model 4: Adjusted further for protein intake, carbohydrate intake, total fat, total calories, fiber intake, and dentist visits, including the variables in model 3.
glucose and fasting insulin, and orange-blue antibody cluster scores were negatively correlated with HbA1c, after accounting for other risk factors in multivariable analyses. The orange-red cluster of antibodies included P. gingivalis, which has been found to be increased among individuals with diabetes (Ebersole et al., 2008; Makiura et al., 2008) . IgG antibody levels against P. gingivalis are highest among individuals with periodontal disease. The IgG levels decline following periodontal treatment; however, they level out but still are higher than levels among individuals who never had periodontal disease (Kudo et al., 2012) . IgG antibodies against P. gingivalis are a marker of periodontal disease among individuals without diabetes (Kudo et al., 2012) and may also be an indicator of periodontal disease in people with diabetes. Another explanation of these findings may be that as P. gingivalis is linked with systemic inflammation (Hayashi et al., 2010) , which can impair insulin action and lead to hyperglycemia (Gregor and Hotamisligil, 2011) . Periodontal treatment has been shown to reduce antibody titers against P. gingivalis (Okada et al., 2013) and improve glycemic control in people with diabetes (Sgolastra et al., 2013) . In hyperglycemia, advanced glycation end products are deposited in the periodontal tissues (Lalla and Papapanou, 2011) , which can lead to increased inflammation and periodontal destruction and possibly increased levels of P. gingivalis and its corresponding antibody titers.
The orange-blue cluster includes A. naeslundii and E. nodatum antibodies; A. naeslundii has been associated with a healthy state in oral Haffajee, 2002, 2005) and systemic ratio, smoking, alcohol, physical activity, dentist visits, body mass index, and waist circumference. Model 4: Adjusted further for protein intake, carbohydrate intake, total fat, total calories, fiber intake, and dentist visits, including the variables in model 3.
conditions (Desvarieux et al., 2013) , albeit through incompletely understood mechanisms. Even though the presence of E. nodatum and T. denticola in the mouth has been associated with periodontal disease (Haffajee et al., 2006) , IgG antibodies against E. nodatum (orange complex), F. nucleatum (orange complex), and T. denticola (red complex) were higher in controls as compared with cases of periodontal disease (Papapanou et al., 2000) . Higher antibody levels against these organisms may prevent subsequent colonization of these organisms in the mouth and thus be protective against new periodontal lesions, which may explain this finding. This study has limitations. First, because of the crosssectional design it was not possible to determine whether antibody titers contributed to hyperglycemia or were a consequence of it. For the same reason, the individuals in the study are prone to survivorship bias because those with more serious disease either died or did not participate in the survey. If the relationship between oral microorganisms and hyperglycemia were indeed causal, this bias would attenuate the associations that we detected. Second, we did not adjust for clinically defined periodontal disease (e.g., clinical attachment loss), because proliferation of periodontal microorganisms precedes periodontal destruction. Clinically defined, periodontal disease is thus on the causal pathway between oral microorganisms and the outcomes, and adjusting for it would cause bias (VanderWeele, 2009 ). The results were qualitatively similar after stratification by periodontal status. Moreover, we previously reported that clinical attachment loss and periodontal pocket depth were positively associated with diabetes and impaired fasting glucose in these data (Choi et al., 2011) . Third, we were able evaluate only 19 of the many oral microorganisms in the mouth. Fourth, we included edentulous individuals in the main analysis because they have elevated IgG antibodies as a result of long-term prior exposure to oral microorganisms. Excluding edentulous individuals did not materially alter the results (Table 3) . Fifth, although the data were not recent (i.e., 1988-1994) and prevalence of disease has changed (Eke et al., 2012) , this should not influence the relation between serum antibodies and measures of hyperglycemia. Last, because this is an observational study, unmeasured confounding is possible, even though we accounted for a number of factors in the analyses. The strengths of this study were as follows: First, this was a large representative population-based sample, reducing the likelihood of false-negative results. To our knowledge, this is the largest study to evaluate the relation between titers against oral microorganisms and hyperglycemia. Second, the antibody titers (Papapanou et al., 2001; Centers for Disease Control and Prevention, 2008) and the outcomes were measured in a standardized way. Third, we adjusted for a number of potential confounders, thereby reducing the chances of bias; moreover, the results were consistent in all analyses. Fourth, we grouped the antibody titers against oral microorganisms via cluster analysis. This method uses the correlations among different variables to form mutually exclusive groups. This was an appropriate method to classify antibodies against the 19 oral microorganisms because the microorganisms are correlated and their roles not yet clearly defined. We obtained cluster scores by summing z scores of the titers. We did this because we were interested in evaluating the relative (rather than absolute) contributions of the titers to the overall score. Forming the clusters also reduced the data, thereby minimizing the chance of spurious results from multiple testing (Wang et al., 2007) . Finally, in the multivariable models, we evaluated the clusters together. Thus, a 1-unit increase in the orange-red titer score represented a corresponding change in a measure of hyperglycemia, holding the other clusters constant. With this approach, we were able to evaluate the composition antibody titers in relation to the outcome. This measure is biologically important because oral microorganisms are ubiquitous and changes in microbial composition occur relative to other organisms in the mouth (Desvarieux et al., 2013; Socransky & Haffajee, 2002 , 2005 .
Groups of antibody titers against periodontal microorganisms were associated with hyperglycemia independent of known risk factors. Antibody titers against periodontal microorganisms may characterize the relation between periodontal disease and hyperglycemia.
